Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in Traumatic Brain Injury
NCT01606111Phase 4Terminated
- Sponsor
- EVER Pharma
- Start
- Sep 2013
- Primary completion
- Jul 2015
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cerebrolysin in traumatic brain injury (TBI), sponsored by EVER Pharma. Started Sep 2013; status: terminated.
02
Drugs
cerebrolysin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01606111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606111.